Viral Immunology, 2018 Measles remains an important cause of child morbidity and mortality worldwide despite the availability of a safe and efficacious vaccine. The current measles virus (MeV) vaccine was developed empirically by attenuation of wild-type (WT) MeV by in vitro passage in human and chicken cells and licensed in 1963.
openaire +2 more sources
Following in the footsteps of smallpox: can we achieve the global eradication of measles? [PDF]
, 2004 BACKGROUND: Although an effective measles vaccine has been available for almost 40 years, in 2000 there were about 30 million measles infections worldwide and 777,000 measles-related deaths.
Morgan, Oliver WC
core +2 more sources
Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update. [PDF]
, 2011 Measles caused mortality in >164,000 children in 2008, with most deaths occurring during outbreaks. Nonetheless, the impact and desirability of conducting measles outbreak response immunization (ORI) in middle- and low-income countries has been ...
Al Wahaibi +60 more
core +2 more sources
EXPERIMENTAL MEASLES VACCINES: A RESEARCH TOOL IN VACCINATION EVENTS
Медицинская иммунология, 2014 . The review article considers different variants of measles vaccine that may be classified into two groups, i.e., vaccines that do not contain viable measles virus, and attenuated measles vaccines which could be employed in unusual manner.The first ...
V. A. Liashenko
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months.
Kalonde Malama +11 more
doaj +1 more source
Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal [PDF]
, 2018 Although most countries in the WHO European Region were verified in 2017 as having interrupted endemic measles transmission, nine countries were still endemic. Among these, Italy accounted for the second highest number of measles cases reported in Europe
Adamo, Giovanna +9 more
core +2 more sources
Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. [PDF]
, 2018 BACKGROUND: High rates of vaccination coverage are important in preventing infectious diseases. Enforcing mandatory vaccinations is one of the strategies that some Countries adopted to protect the community when vaccination coverage is not satisfactory ...
Bozzola E +5 more
core +2 more sources
Measles vaccination of special risk groups
Human Vaccines & Immunotherapeutics, 2021 Measles is an important vaccine preventable disease with significant morbidity and mortality. Although measles vaccine is a safe and effective vaccine available worldwide for more than 50 years, still immunization efforts have not successfully reached ...
Vassiliki Papaevangelou
doaj +1 more source
Laboratory diagnosis of vaccine-associated measles in Zhejiang Province, China
Journal of Microbiology, Immunology and Infection, 2017 Background/Purpose: Along with the improving vaccine coverage, suspected vaccine-associated measles has been reported in Zhejiang Province, China. In order to maintain the accuracy of the measles surveillance system, it is critical to discriminate ...
Chang-Ping Xu +4 more
doaj +1 more source
Advances in the design and development of oncolytic measles viruses. [PDF]
, 2015 A successful oncolytic virus is one that selectively propagates and destroys cancerous tissue without causing excessive damage to the normal surrounding tissue. Oncolytic measles virus (MV) is one such virus that exhibits this characteristic and thus has
Hutzen, Brian +2 more
core +1 more source